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Summary
To identify new genetic regulators of cellular aging and
senescence, we performed genome-wide comparative
RNA proﬁling with selected human cellular model sys-
tems, reﬂecting replicative senescence, stress-induced
premature senescence, and distinct other forms of cellular
aging. Gene expression proﬁles were measured, ana-
lyzed, and entered into a newly generated database
referred to as the GiSAO database. Bioinformatic analysis
revealed a set of new candidate genes, conserved across
the majority of the cellular aging models, which were so
far not associated with cellular aging, and highlighted
several new pathways that potentially play a role in cellu-
lar aging. Several candidate genes obtained through this
analysis have been conﬁrmed by functional experiments,
thereby validating the experimental approach. The effect
of genetic deletion on chronological lifespan in yeast was
assessed for 93 genes where (i) functional homologues
were found in the yeast genome and (ii) the deletion
strain was viable. We identiﬁed several genes whose
deletion led to signiﬁcant changes of chronological life-
span in yeast, featuring both lifespan shortening and life-
span extension. In conclusion, an unbiased screen across
species uncovered several so far unrecognized molecular
pathways for cellular aging that are conserved in
evolution.
Key words: aging; evolution; replicative lifespan; replica-
tive senescence; senescence; yeast.
Introduction
A major goal in current aging research is to understand genetic
regulation of aging in humans. However, many recent insights
into genetic determinants of aging have been gained from stud-
ies withshort-lived eukaryotic modelsystemsofaging [forrecent
review, see (Partridge, 2009)], which, unlike human beings, are
amenable to molecular genetic analysis in the laboratory. Extrap-
olation of results obtained in lower model organisms identiﬁed
cellularpathwayssuchastheinsulin⁄IGFpathway(Holzenberger,
2004;Katic&Kahn,2005),whichareconservedinevolution and
appear to modulate aging in a variety of organisms including
mammals (Bartke, 2005). Although it is very likely that these very
same mechanisms also modulate aging in humans, this has not
yet been formally proven. Moreover, extrapolating ﬁndings in
lower model organisms to more complex organisms, such as
humans, bears the inherent risk that some pathways, which are
lessimportantorabsentthere,maybeoverlooked.
To circumvent this potential problem, we applied an alterna-
tive strategy, namely to employ human model systems of cellular
aging and senescence as the primary screening system. There is
now increasing evidence that the appearance of cellular senes-
cence contributes to the aging of tissues, such as the skin (Dimri
et al., 1995; Ressler et al., 2006), the vascular system (Vasile
et al., 2001; Minamino et al., 2002; reviewed by Erusalimsky,
2009), and the kidney (Melk & Halloran, 2001). We performed
genome-wide RNA proﬁling on several experimental models for
cellular senescence, including stress-induced premature senes-
cence (SIPS), replicative senescence, and other distinct forms of
cellular aging, as proposed recently (Lepperdinger et al., 2008;
Hackl et al., 2010) and collected the data in a novel database
referred to as the GiSAO (genes involved in senescence, apopto-
sis, and oxidative stress) database. Comparison of the differen-
tial gene expression patterns of the models should in turn unveil
distinct novel genetic regulators of cellular aging. Potentially,
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lthe information obtained from these experiments, when ﬁltered
accordingly, should provide molecular information about highly
conserved gene expression patterns related to cellular aging.
Because of the genome-wide approach, the data collected from
cell types as diverse as those employed herein should also
uncover recurrent cellular alterations indicative for hitherto
unknown biological aging mechanisms. As a further step in eval-
uation of the functional role of the individually selected genes,
those that were also found to be highly conserved during phy-
logeny were taken to functional tests in yeast deletion strains
thereby monitoring the respective lifespan of the mutant
organisms.
Results
Comparative RNA proﬁling of aging and senescence
in human cellular models
Accumulation of damage is considered a key factor driving cellu-
lar aging, and oxidative stress is a common denominator of
stress that induces cellular senescence in vitro in a variety of cell
types (Dumont et al., 2000). To identify key transcriptional
events preceding senescence induced by oxidative stress, a com-
prehensive set of human cellular models were subjected to oxi-
dative stress at doses known to elicit a senescence response. The
corresponding model systems are referred to as experimental
group 1 (EG1) (Table 1). For comparison, other model systems
of cellular aging were also analyzed collectively referred to as
experimental group 2 (EG2) (Table 1). On the one hand, we
used models of in vitro cellular senescence not triggered by oxi-
dative stress, namely replicative senescence of human umbilical
vein endothelial cells (HUVEC) and renal proximal tubular epithe-
lial cells (RPTEC). Similarly, we applied primary foreskin ﬁbro-
blasts (PFF) in which premature senescence was induced by
mitochondrial dysfunction (Passos et al., 2007), which is largely
independent of oxidative stress (Stockl et al., 2007). On the
other hand, three alternative models of cellular aging (included
in experimental group 2, see Table 1) were also analyzed: ﬁrst,
we compared CD28
) and CD28
+ CD8
+ T lymphocytes, based on
the assumption that the increased percentage of CD28
+ T cells
result from high level cell proliferation and hence represent a
form of in vivo senescence (Rufer et al., 2003; Lazuardi et al.,
2009). Furthermore, we also analyzed differences in the gene
expression proﬁles of mesenchymal stem cells (MSC) obtained
from young and old human donors, another system that permits
the impact of human donor age on cellular phenotype to be
assessed (Fehrer et al., 2007). Finally, we also analyzed gene
expression proﬁles of prostate stromal cells (PrSC), which were
driven to transdifferentiate into premature senescent myoﬁbro-
blasts by TGFb1, a process considered a hallmark of the aging
human prostate, leading to benign prostatic hyperplasia
(Untergasser et al., 2005). RNA was prepared from all samples
and analyzed on Affymetrix arrays for whole-genome expression
proﬁling. For validation purposes, the expression levels of 22
genes, which were found to be differentially expressed in a high
number of individual experiments, were determined by quanti-
tative reverse transcription–PCR (qPCR). Good concordance
between data of the microarray and qPCR analyses was
obtained. Linear regression yielded an r-value of 0.68 and 362
of 380 individual experimental data pairs sitting within the 95%
prediction interval (Fig. S1).
Identiﬁcation of transcriptional signatures of
oxidative stress and cellular aging
For computational comparison, normalized whole-genome
expression proﬁles from 47 independent experimental samples
were established (Table 1), and hierarchical clustering of the
gene expression proﬁles derived from all experimental human
cell models was performed (Fig. S2). Differential expression val-
ues were calculated and compiled for further analysis by assem-
bling 35 pairs of individual experiments with regard to cellular
aging or oxidative stress (Fig. 1; see also Table S1). Considerable
resemblance with respect to sets of differentially expressed
genes was observed between HUVEC and RPTEC that have
undergone replicative senescence, in vivo aged CD8 T cells and
MSC, as well as in a compilation of these experimental model
systems (Fig. S3).
Several methods have been established to identify genes that
are differentially expressed in a homologous set of biological
replicates. However, complex datasets such as those described
herein, which comprise transcriptional proﬁles from different
cell types derived from differently aged, nonrelated human indi-
Table 1 Overview microarray experiments: experimental model systems:
HUVEC, human umbilical vein epithelial cells; PFF, primary foreskin ﬁbroblasts;
PrSC, primary prostatic stromal ﬁbroblasts; RPTEC, renal proximal tubular
epithelial cells; CD8, CD8
+ T lymphocytes; MSC, mesenchymal stem cells;
reagents: t-BHP (tert-butylhydroperoxide), FCCP (carbonyl cyanide
p-(triﬂuoromethoxy)phenylhydrazone), AMP (adenosine monophosphate);
number of array hybridizations ⁄samples; number of array experiments for
senescence and oxidative stress; EMBL-EBI Array Express accession number
Cell
type
Controls
Experimental
group 1
(oxidative stress)
Experimental
group 2
(cellular aging)
Array Express
accession
number
No. of
arrays Treatment
No. of
arrays Treatment
No. of
arrays
HUVEC 6 t-BHP 2 RS 2 E-MEXP-2283
PFF 8 ND ND FCCP 2 E-MEXP-2285
AMP 2
Oligomycin 2
RPTEC 4 ND ND RS 1 E-MEXP-2683
High ⁄ low ROS 1
PrSC 10 t-BHP 2 TGF-b (trans-
differentiation)
2 E-MEXP-2167
20% vs.
3% O2
4
CD8 15 t-BHP 7 CD28
) ⁄ CD28
+ 4 E-MEXP-2345
MSC 4 20% vs.
3% O2
2 Young vs. old
donor
2 E-MEXP-1506
Total 47 17 18
RS, replicative senescence; ND, not determined.
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1085viduals, often show highly variable transcript levels with regard
to the expression of individual genes (Lu et al., 2004; Rodwell
et al., 2004; Tan et al., 2005; Lener et al., 2006). This can be
either because of variant genetic background or the redundant
use of closely related homologous genes. Therefore, we
employed a value counting method.
The number a particular gene was found under- or overex-
pressed was counted, and the list of all genes was sorted accord-
ing to occurrence. Using this methodology, we identiﬁed 586
probe sets representing 484 genes across EG1 with differential
expression (DE) higher than ±1.5-fold in more than 50% of indi-
vidual pair-wise comparisons, and 1423 probe sets representing
1087 genes across EG2, again with the same criteria of
DE > ±1.5 in > 50% of experiments, whereas 180 probe sets
representing 155 genes were present in both data sets. With
respect to a cumulative binomial distribution (CBD), we addi-
tionally calculated P-values together with the corresponding q-
values (Table S2) yielding a probability of 0.12 for any probe set
to be differentially expressed with senescence and a probability
of 0.11 for a probe set to be differentially expressed with oxida-
tive stress. The q-values were £ 0.0030 in both EG1 and EG2,
and P-values were £ 0.000028 in EG1 and £ 0.000085 in EG2
(Table S2). When evaluating both experimental groups along
these lines, we revealed a set of 335 candidate genes with
DE > ±1.5 in at least 18 pair-wise comparisons (Table S3).
The highest overall score (with most occurrences of DE) was
observed for PAF (PCNA associated factor) (Table 2A) (Yu et al.
2001), a gene recently reported to be involved in DNA repair in
HeLa cells (Turchi et al., 2009). Another top scoring gene was
SKP2 (Table 2A), encoding a regulatory subunit of an ubiquitin
ligase complex, which was recently identiﬁed as playing a key
role in setting the threshold for stress-induced cellular senes-
cence (Lin et al., 2010). Several additional genes were identiﬁed
with high scores, such as SLC1A4, a member of the solute car-
rier family 1 (Table 2A), which so far have not been linked to the
senescent phenotype. Of note, four genes involved in the regu-
lation of transcription (BHLHB2, TCF8, RUNX1, and TCEA3) were
included in the top 15 genes common to both experimental
groups (Table 2A).
When both experimental groups were treated separately,
the highest scoring genes (with most occurrences of DE) for
experimental group 1 (oxidative stress) were genes involved in
regulating cell proliferation, such as RRM2, cyclin B2, EGR1, and
IGFBP-3 (Table 2B), consistent with the induction of rapid
growth arrest by oxidative stress (Chen & Ames, 1994). In
addition, several genes were identiﬁed for which a role in stress-
induced senescence was not known before, such as the transla-
tion initiation factors EIF4A and EIF5A (Table 2B). The highest
scoring genes (with most occurrences of DE) for experimental
group 2 (cellular aging) are shown in Table 2C. Surprisingly, the
Fig. 1 Workﬂow for candidate gene identiﬁcation and functional classiﬁcation. First, gene expression data from 47 microarrays were processed to identify
differentially expressed (DE) genes in experimental group 1 (EG1) and experimental group 2 (EG2). The selection of genes for functional classiﬁcation and pathway
analysis, starting from a total of 1566 genes, is shown (left arm). In the right arm of the diagram, the strategy to identify yeast genes for testing in lifespan analysis
is depicted.
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1086Table 2 (A) Genes that were found differentially expressed with highest occurrence in both experimental groups, (B) group 1 (oxidative stress), (C) group 2
(cellular aging)
Symbol Description Unigene GenBank
EG1
up
EG1
down
EG2
up
EG2
down
EG1 +
EG2DE
(A)
KIAA0101 KIAA0101 ⁄ PAF Hs.81892 NM_014736 7 7 6 7 27
APOBEC3G Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3G Hs.660143 NM_021822 0 10 8 8 26
MEST Mesoderm-speciﬁc transcript homolog (mouse) Hs.270978 NM_002402 4 5 8 8 25
RRM2 Ribonucleotide reductase M2 polypeptide Hs.226390 BE966236 7 5 4 9 25
SYDE2 Synapse defective 1, Rho GTPase, homolog 2 (C. elegans) Hs.718601 N90719 7 5 5 8 25
TXNIP Thioredoxin interacting protein Hs.715525 AA812232 2 9 7 7 25
BHLHB2 Basic helix-loop-helix domain containing, class B, 2 Hs.719093 NM_003670 5 6 10 3 24
BICD1 Bicaudal D homolog 1 (Drosophila) Hs.505202 BC010091 10 3 7 4 24
CYP51A1 Cytochrome P450, family 51, subfamily A, polypeptide 1 Hs.417077 U40053 10 1 10 3 24
HMGCS1 3-hydroxy-3-methylglutaryl-Coenzyme A synthase 1 (soluble) Hs.397729 NM_002130 9 3 9 3 24
SKP2 S-phase kinase-associated protein 2 (p45) Hs.23348 BC001441 5 9 3 7 24
SLC1A4 Solute carrier family 1 (neutral amino acid transporter), member 4 Hs.654352 W72527 6 1 11 6 24
TCF8 Transcription factor 8 (represses interleukin 2 expression) Hs.282113 NM_030751 6 6 6 6 24
C20orf129 Chromosome 20 open reading frame 129 Hs.472716 BC001068 11 1 7 4 23
CD302 CD302 antigen Hs.130014 NM_014880 7 4 6 6 23
IFI44L Interferon-induced protein 44-like Hs.389724 NM_006820 3 7 8 5 23
PDGFD Platelet derived growth factor D Hs.352298 NM_025208 5 4 6 8 23
RUNX1 Runt-related transcription factor 1 (acute myeloid leukemia 1) Hs.675708 BU789637 2 9 9 3 23
TCEA3 Transcription elongation factor A (SII), 3 Hs.446354 AI675780 2 8 4 9 23
TSPAN2 Tetraspanin 2 Hs.310458 AI743596 4 6 7 6 23
Symbol Description Unigene GenBank
EG1
up
EG1
down
EG1
DE
(B)
KIAA0101 KIAA0101 ⁄ PAF Hs.81892 NM_014736 7 7 14
RRM2 Ribonucleotide reductase M2 polypeptide Hs.226390 BC001886 8 6 14
SKP2 S-phase kinase-associated protein 2 (p45) Hs.23348 BC001441 5 9 14
TRPV2 Transient receptor potential cation channel, subfamily V, member 2 Hs.279746 NM_015930 4 10 14
BICD1 Bicaudal D homolog 1 (Drosophila) Hs.505202 BC010091 10 3 13
EIF4A2 Eukaryotic translation initiation factor 4A, isoform 2 Hs.518475 AI332397 10 3 13
NQO1 NAD(P)H dehydrogenase, quinone 1 Hs.406515 NM_000903 9 4 13
C20orf129 Chromosome 20 open reading frame 129 Hs.472716 BC001068 11 1 12
CASP1 Caspase 1, apoptosis-related cysteine peptidase (interleukin 1, beta,
convertase)
Hs.2490 U13699 2 10 12
CCNB2 Cyclin B2 Hs.194698 NM_004701 5 7 12
CIRBP Cold-inducible RNA-binding protein Hs.634522 AL565767 8 4 12
CKAP2 Cytoskeleton-associated protein 2 Hs.444028 NM_018204 11 1 12
CYBA Cytochrome b-245, alpha polypeptide Hs.513803 NM_000101 3 9 12
DAAM1 Disheveled-associated activator of morphogenesis 1 Hs.19156 AA890373 8 4 12
EGR1 Early growth response 1 Hs.326035 NM_001964 6 6 12
EIF5A Eukaryotic translation initiation factor 5A Hs.534314 NM_001970 11 1 12
ERRFI1 ERBB receptor feedback inhibitor 1 Hs.658370 AW612461 7 5 12
FBXO9 F-box protein 9 Hs.216653 AK095307 8 4 12
HMGCS1 3-hydroxy-3-methylglutaryl-Coenzyme A synthase 1 (soluble) Hs.397729 NM_002130 9 3 12
IGFBP3 Insulin-like growth factor binding protein 3 Hs.450230 BF340228 4 8 12
Symbol Description Unigene GenBank
EG2
up
EG2
down
EG2
DE
(C)
SLC1A4 Solute carrier family 1 (neutral amino acid transporter), member 4 Hs.654352 BF340083 11 7 18
ARRB1 Arrestin, beta 1 Hs.503284 BE207758 8 9 17
APOBEC3G Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3G Hs.660143 NM_021822 8 8 16
MEST Mesoderm-speciﬁc transcript homolog (mouse) Hs.270978 NM_002402 8 8 16
CTSC Cathepsin C Hs.128065 AI246687 10 5 15
METTL7A Methyltransferase like 7A Hs.716437 NM_014033 10 5 15
GLIPR1 GLI pathogenesis-related 1 (glioma) Hs.205558 AV682252 7 8 15
RAB27B RAB27B, member RAS oncogene family Hs.25318 BF438386 11 4 15
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1087top 15 genes in this group were distinct from the top scorers
obtained in experimental group 1. Moreover, most of the genes
identiﬁed in this approach were not previously associated with
cellular senescence. Hence, this list of genes may contain novel
information about potential unidentiﬁed regulators of cellular
aging, probably including genes that are relevant for cellular
aging in vivo. The regulation of selected genes was also
addressed at the protein level. On the one hand, selected genes
were analyzed across all cellular model systems. For example,
protein levels were determined for the conserved candidate
gene EZH2 (DE = 19; Table S2), coding for a histone methyl-
transferase that plays a major role in epigenetic regulation of
senescence (Bracken et al., 2007.). Consistent with data
obtained by RNA proﬁling, EZH2 protein level was considerably
reduced in senescent RPTEC and HUVEC, as well as in PFF after
treatment with adenosine monophosphate (AMP) and carbonyl
cyanide 4-(triﬂuoromethoxy)phenylhydrazone (FCCP) but not
oligomycin (Fig. 2A). EZH2 levels were not signiﬁcantly regu-
lated in MSC, PrSC, and CD8 T lymphocytes (Fig. 2B, C) consis-
tent with the results of RNA proﬁling. Additional protein
analyses were performed for relevant proteins selectively in
particular model systems. Thus, we conﬁrmed by Western blot
upregulation of IGFBP-3 in trans-differentiated PrSC and MSC
grown in a hyperoxic atmosphere (Fig. 2B). In additional experi-
ments, we conﬁrmed the upregulation of IGFBP-3 and IGFBP-6
in cellular supernatants by ELISA and the downregulation of
IGF1R in CD8
+CD28
) T lymphocytes by antibody assisted ﬂow
cytometry (data not shown).
(A)
(B) (C)
Fig. 2 Western blot analysis. Cell lysates were prepared from various model systems employed in this study: young and senescent human umbilical vein
endothelial cells and renal proximal tubular epithelial cells, respectively; PFF treated with FCCP, AMP, and oligomycin for three days (A); mesenchymal stem cells
cultured at atmospheric conditions of 3% or 20% oxygen; prostate stromal cells treated with either basic ﬁbroblast growth factor (bFGF) or transforming growth
factor beta 1 (TGFb1) (B); CD8 T cells either isolated from a young or an elderly donor and sorted with respect to CD28 (C); Proteins were analyzed by
immunoblotting using antibodies to EZH2, ALDH2, cystathionine beta-synthase, and IGFBP3, as indicated. For loading control, antibodies to b-actin and GAPDH
were used as indicated.
Table 2 (Continued)
Symbol Description Unigene GenBank
EG2
up
EG2
down
EG2
DE
TRIB3 Tribbles homolog 3 (Drosophila) Hs.516826 NM_021158 10 5 15
ABL2 v-abl Abelson murine leukemia viral oncogene homolog 2 Hs.159472 AK025877 9 5 14
EIF4EBP1 Eukaryotic translation initiation factor 4E binding protein 1 Hs.411641 AB044548 8 6 14
ETV1 ets variant gene 1 Hs.22634 BE881590 9 5 14
IFIT3 Interferon-induced protein with tetratricopeptide repeats 3 Hs.714337 AI075407 7 7 14
KLF9 Kruppel-like factor 9 Hs.150557 AI690205 3 11 14
MCC Mutated in colorectal cancers Hs.593171 BE967311 3 11 14
PDGFD Platelet derived growth factor D Hs.352298 NM_025208 6 8 14
PHGDH Phosphoglycerate dehydrogenase Hs.487296 NM_006623 4 10 14
PHLDA1 Pleckstrin homology-like domain, family A, member 1 Hs.602085 AK026181 10 4 14
PTGS2 Prostaglandin-endoperoxide synthase 2 Hs.196384 NM_000963 8 6 14
RAB1A RAB1A, member RAS oncogene family Hs.709257 BG530481 4 10 14
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1088Pathway analysis
To analyze the large amount of gene expression data in a
user-friendly way and for optimal data mining, a database was
constructed referred to as the GiSAO database (‘Genes Involved
in Senescence, Apoptosis and Oxidative stress’ (Lepperdinger
et al., 2008); for details, see ‘Experimental procedures’). Cur-
rently, more than a hundred whole-genome array data sets
fulﬁlling MIAME criteria from cellular aging model systems were
deposited by this consortium in the GiSAO database (https://
gisao.genome.tugraz.at/gisao_web/), also including the data-
sets of miRNA expression published recently (Hackl et al., 2010).
To identify principal biological processes associated with age-
related transcriptional changes, we ﬁrst evaluated top-ranked
genes via Pathway Explorer (Mlecnik et al., 2005), a web-acces-
sible tool that allows life scientists to infer the biological mean-
ing behind large gene lists. Pathway analysis for genes that are
DE in both experimental groups highlighted the p53 signaling
pathway, apoptosis, and cell cycle regulation as the most rele-
vant pathways. The general importance of pathways controlling
cell proliferation and cell death for cellular senescence is well
established (Mallette & Ferbeyre, 2007). Thus, these observa-
tions validate our experimental approach. The analysis identiﬁed
additional pathways that were signiﬁcantly overrepresented
(P < 0.001) in the group of differentially regulated genes, which
have not previously been linked to cellular senescence, such as
cholesterol biosynthesis, IL-18 signaling, and nitrogen metabo-
lism (Table 3).
Pathway analysis was also separately applied to experimental
groups 1 and 2. For genes differentially expressed in experimen-
tal group 1 (oxidative stress), the highest ranked clusters were
related to the regulation of apoptosis and cell cycle, in particular
the G1⁄S transition. Additionally, chromosome maintenance,
lipid biosynthesis, D4-GDI signaling, and DNA replication scored
highly signiﬁcant (P < 0.001). Among the genes differentially
expressed in experimental group 2, top clusters related to apop-
tosis, MAPK signaling, and extracellular matrix. In addition,
highly signiﬁcant scores (P < 0.001) were observed for p53
signaling, enzyme inhibitor activity, cell cycle regulation, cell
surface receptor linked signal transduction, and cell growth. In
this group, we also noted a high representation of the Wnt
signaling pathway and cytokine–cytokine receptor interactions,
two pathways previously linked with cellular senescence (Ye
et al., 2007; Acosta et al. 2008; Coppe et al., 2010b); however,
in both cases, statistical signiﬁcance was rather weak.
Functional validation of candidate genes by lifespan
analysis in yeast mutants
Next, potential homologues of the human candidate genes were
identiﬁed in the genome of budding yeast, Saccharomyces cere-
visiae. To this end, an extended list of human genes was com-
piled with differential expression (DE > 1.5) in at least 6 of 17
experiments in experimental group 1 or at least 6 of 18 experi-
ments in experimental group 2 (Fig. 1). Both upregulated and
downregulated genes were considered. Starting with a total of
6750 human genes, 553 yeast orthologs were identiﬁed, of
which only the nonessential genes were considered for further
analysis. For the top ranking human genes, 93 nonessential
yeast orthologs were identiﬁed (Table S4). Subsequently, func-
tional tests regarding long-term proliferation were performed,
and the viability of the respective mutant yeast strain was vali-
dated. The deletion mutants of the corresponding S. cerevisiae
homologues were obtained from the EUROSCARF knockout
strain collection. A panel of yeast mutant cells in stationary
phase was analyzed by chronological lifespan experiments
(MacLean et al., 2001; Piper, 2006) involving 22-day culturing in
stationary phase as described (Fabrizio et al., 2004; Herker
Table 3 Pathway analysis: functional classiﬁcation of genes that are
differentially expressed in experimental groups 1, 2 or both, using Pathway
Explorer (Mlecnik et al., 2005; available online: https://pathwayexplorer.
genome.tugraz.at/), gene number attributed to pathway, P-values were
calculated from complete expression value dataset (54 675 probe sets) with
Fisher’s exact test, where gene numbers are given, all P-values are < 0.05
Pathway
Gene number
EG1
Gene number
EG2
Gene number
EG1 + EG2
Apoptosis 17 39 7
Cell cycle 15 27 7
p53 signaling pathway 7 32 7
Cell proliferation * 32 7
Chromosome 14 * 5
Lipid biosynthesis 13 * 4
Cytokinesis 10 * 5
Pyrimidine metabolism 9 * 3
G1 to S cell cycle control 8 * 3
mRNA metabolism 10 * *
ATP-dependent
helicase activity
9* *
Fatty acid metabolism 9 * *
mRNA processing 9 * *
D4-GDI signaling pathway 7 * *
DNA replication 7 * *
MAPK signaling pathway * 36 *
Extracellular matrix * 33 *
Focal adhesion * 29 *
Enzyme inhibitor activity * 28 *
Cytokine–cytokine
receptor interaction
*2 7*
Cell growth * 24 *
Cell surface receptor
linked signal transduction
*2 4*
Wnt signaling pathway * 24 *
Cholesterol biosynthesis * * 3
Fructose and mannose
metabolism
** 3
IL 18 signaling pathway * * 2
Nitrogen metabolism * * 3
Synthesis and degradation
of ketone bodies
** 2
*No genes were found for particular pathway or P > 0.05.
Pathway data source: KEGG pathway database (http://www.genome.jp/
kegg/pathway.html), GenMapp (http://www.genmapp.org/), Biocarta
(http://www.biocarta.com/genes).
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1089et al., 2004). As control, wild-type strains were also analyzed,
which have a mean lifespan of about 11 days under these condi-
tions (Fabrizio et al., 2004; Herker et al., 2004). Twenty-two
days after the start of the experiment, the wild-type strain
completely ceased growth and was all found dead. The 93
selected yeast mutant strains displayed signiﬁcantly different
survival rates (Table 4), ranging from drastic lifespan shortening
to lifespan extension relative to wild-type cells. For a more
detailed analysis, the lifespan data were repeated for the nine
most short-lived strains containing mutations in ATG18, GCM5,
KGD1, LYS69, MSW1, NCR1, TIM1, RAD27, and SHM1. Life-
span shortening relative to the wild-type was highly reproduc-
ible (Fig. 3A), with the disruption of KGD1, MSW1, and TIM1
having the greatest effect on lifespan, suggesting that these
genes play important roles for survival in stationary culture. Simi-
larly, yeast mutants with extended lifespan were also identiﬁed
(Table 4), and a signiﬁcant extension of lifespan was obtained
for the mutants DCYS4, DALD4, and DPDX3 (Fig. 3B). Whereas
yeast strains mutated in UBC12 and PAS3 showed a trend for
extended lifespan, this did not reach statistical signiﬁcance. The
CYS4 gene encodes a cystathionine beta-synthase involved in
the ﬁrst step of cysteine biosynthesis while Ald4p is the major
aldehyde dehydrogenase isoform. PDX3, encoding pyridoxine
(pyridoxamine) 5¢-phosphate oxidase, is involved in the salvage
pathway of pyridoxal 5¢-phosphate. As a ﬁrst step to address the
relevance of the human orthologs in our cellular senescence
models, expression and regulation of ALDH2 and cystathionine
beta-synthase (CBS) was analyzed by Western blot. ALDH2
protein level was upregulated in senescent RPTEC and in
FCCP-treated PFF (Fig. 2), but remained unchanged in the other
experimental models (Fig. 2 and data not shown). Cystathionine
beta-synthase protein level was downregulated with senescence
in both HUVEC and RPTEC, as well as in AMP-treated PFF
(Fig. 2), consistent with the data obtained by RNA proﬁling. In
contrast, CBS was not signiﬁcantly regulated in the other cellular
model systems (data not shown). Together, the data suggest
that the levels of ALDH2 and CBS gene products are indeed reg-
ulated by the various treatments, in most cases reﬂecting the dif-
ferential expression values as elucidated by our initial genomic
screening method. The pattern of regulation is complex in both
cases, and more work is required to understand the exact contri-
bution of these genes to cellular senescence.
Discussion
The here presented analysis has identiﬁed gene expression sig-
natures of cellular aging, which are conserved between different
human tissues. The experimental design was based on the
assumptions that (i) genes that are differentially regulated in
human cellular aging and senescence are trustworthy candi-
dates for modulators of aging and that (ii) the ability of a certain
gene to restrict lifespan in yeast suggests that this gene has a
role in modulating the rate of aging that potentially extends
beyond yeast. This analysis revealed several genes and molecular
pathways already known to be involved in aging, thereby vali-
dating the screen. In addition, a reasonable number of novel
genes and a few novel pathways were identiﬁed that have not
beenlinkedtoagingbefore. Basedon theseﬁndings,new exper-
imental approaches tostudy humanaging will becomepossible.
Model systems for cellular aging
According to current hypotheses, aging at the cellular level
contributes signiﬁcantly to organismic aging, and for a better
understanding of human aging, cellular model systems are
indispensible (Campisi, 2005; Toussaint et al., 2002a, 2002b).
Several model systems for cellular aging have been developed,
and a representative selection of these models was applied for
the present study: replicative senescence, a process of cellular
aging in vitro that is primarily driven by telomere erosion, is a
classic experimental system considered relevant for the aging of
tissues with high regenerative potential (von Figura et al.,
2009). In addition to replicative senescence, most if not all pri-
mary human cells can be driven into premature senescence by
various stressors, in a process which does not necessarily involve
telomere shortening. It is assumed that SIPS is relevant for aging
of both mitotic and postmitotic tissues (Toussaint et al., 2002a,
2002b). The importance of SIPS for in vivo aging is supported by
the fact that SIPS can be induced in vitro by factors that are well-
known risk factors for age-associated degeneration of the corre-
sponding tissue in vivo. For example, vascular endothelial cells
undergo SIPS in response to oxidative stress, high glucose, shear
stress, and incubation with oxidized LDL, all of which are known
risk factors for age-associated vascular dysfunction and disease
(Erusalimsky & Kurz, 2006; Goligorsky et al., 2009). Three
additional model systems of cellular aging, with a particular
Table 4 Effects on chronological aging observed in 93 single deletion
strains: deletion strains were assigned to ﬁve categories, depending on the
effects on survival during aging when compared to the wild-type
Survival during chronological
aging (compared to WT) Single deletion of
Strongly reduced
(< 50% of wt)
KGD1, SOD2, RPL31A, NCR1, LYS9,
SHM1, GCN5, HAP3, PIM1, PRY1,
ATG18, CYC1, RPL13B, MSW1, RAD27,
YDC1, TIF3
Slightly reduced
(> 50% and < 85%)
CLB1, CLB2, APM1, SYM1, IDP2, GSY2,
ALT2, SIZ1, TIF1, TIF2, NPL3, PTC5,
RNR3, ERG24, MRT4, MSH6, NUP170,
HAT1, INP53, SSO1, TWF1, SGT2,
LHS1, RPL37A, ARF1, DHP5, CHL1,
TRX1, UBC8, CHD1, SPE2, HRT3,
MRE11, MSH2, DBP1, SSN3, SSF1
Not affected
(same as wt ±15%)
HTA2, AIP1, HXK1, SER1, YPK2,
UBC11, ENO1, RPL22B, RPL43B,
PEX13, REV3, SYG1, MSH5, ERP6,
TPK1, PER1, URA2, SLH1, CHK1, ALD5,
CAF40
Slightly increased
(> 115% and < 150%)
MAD2, PCH2, YTA7, PHO89, UGA1,
DIE2, CAF17, HMT1, ALG5, SSA3, LSB6
Strongly increased
(> 150%)
CYS4, DNF1, ALD4, PDX3, RNH201,
UBC12, PRS3
Genetic regulators of cell aging, G. T. Laschober et al.
ª 2010 The Authors
Aging Cell ª 2010 Blackwell Publishing Ltd/Anatomical Society of Great Britain and Ireland
1090focus on aging in vivo, were included in the analysis: ﬁrst, we
compared CD28
) and CD28
+ CD8
+ T lymphocytes, described
as one of the rare models for in vivo senescence (Rufer et al.,
2003; Lazuardi et al., 2009); second, we compared MSC freshly
obtained from young and old human donors (Fehrer et al.,
2007); ﬁnally, PrSC were included, which can be transdifferenti-
ated into premature senescent myoﬁbroblasts, a process consid-
ered a hallmark of the aging human prostate (Untergasser et al.,
2005). These cellular model systems were developed by the
participating laboratories and are not easily available elsewhere.
Information on genetic regulators of cellular aging obtained
from these systems is considered particularly valuable, given the
scarcity of knowledge on molecular genetic processes involved
in human aging.
The GiSAO database
Otherresourceshavebeencreatedtosystematicallycomparethe
inﬂuenceofthegenomeonagingprocesses.Ofnote,theHuman
Ageing Genomic Resources (HAGR) (de Magalhaes et al., 2005)
represent a systematic collection of genomic data relevant for
aging processes. It consists of the database GenAge featuring
genes associated with aging and longevity in short-lived model
organisms and humans, and AnAge, a database of aging in
animals, featuring information on aging processes in over 4000
animal species (de Magalhaes et al., 2009a, 2009b). The GiSAO
database established in the current communication focuses on
genetic regulation of aging at the cellular level, based on human
gene expression data, and allows the identiﬁcation of evolu-
tionarily conserved regulators of cellular aging. In our view,
information contained in the GiSAO database conveniently
complements the data on organismic aging available in the
HAGR. We have compared data sets in both studies. Indeed, sev-
eralgeneswithahighscoreinthemeta-analysis describedearlier
(de Magalhaes et al., 2009a, 2009b), including TXNIP, S100A4,
and MT1F, featured prominently in our analysis described here
(Table S3). In turn, 15 genes taken from Table S3, including
IGFBP-3,PTGS2,EGR1,FOS,ATM,DDIT3(DE ‡ 20)arealsohigh-
lighted as potential regulators of aging in the HAGR database.
Hence,futureattemptstolinkbothresourcesarewarranted.
(A)
(B)
Fig. 3 Functional analysis of selected candidate genes in yeast. Lifespan data for the nine yeast mutants with shortest lifespan (A) and for the seven mutants with
lifespan extension (B) are shown. (*P < 0.05; **P < 0.01; ***P < 0.001).
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genes⁄pathways with aging
Several of the pathways highlighted in the current analysis have
been associated with aging in cellular senescence and⁄or animal
models before. For example, apoptosis regulation (Campisi,
2003), MAP kinase signaling (Maruyama et al., 2009), p53 sig-
naling (Zuckerman et al., 2009), control of cell proliferation and
cell cycle (Chen, 2000), cytokine–cytokine receptor interaction
(Coppe et al., 2010a), and Wnt signaling (Ye et al., 2007) are
thought to contribute to cellular senescence and aging. In addi-
tion, several of the genes identiﬁed in the unbiased screen
described here were found to play important roles as regulators
of senescence. Thus, Skp2 (Lin et al., 2010) and EZH2 (Bracken
et al., 2007) are known to contribute to the senescence
response in various cell types. Work in the consortium estab-
lished the genes coding for IGFBP-3 (Kim et al., 2007; Muck
et al., 2008), glutaminase (Unterluggauer et al., 2008), and
IGFBP-6 (Micutkova et al., submitted) as functional regulators of
cellular senescence. The prominent appearance of these path-
ways and genes in our screening results serves as positive control
and indicates that the screening procedure was adequate.
Identiﬁcation of novel genes⁄pathways related to
aging
Some interesting human genes, e.g. genes related to cholesterol
biosynthesis, came up in our screen, which have not been
related to aging before. Similarly, genes related to the regulation
of focal adhesion, extracellular matrix, mRNA metabolism, fatty
acid metabolism, and lipid biosynthesis were not known to be
associated with aging processes. Although many of these genes
could not be analyzed in yeast because there are no obvious
orthologs in the yeast genome, these observations will stimulate
future research on the role of the respective genes⁄pathways
both in short-lived model organisms of aging and in human
cellular aging.
Using extension of the chronological lifespan in yeast, which
depends far less on cell-to-cell communication compared to
higher organisms, as an additional screening tool, we expected
to identify primarily basic cell autonomous mechanisms of
aging. In this category, three genes particularly stood out, as
follows: (i) ALD4, the major (mitochondrial) aldehyde dehydro-
genase isoform, which is involved in the degradation of various
amino acids and fatty acids in yeast, whereas the human homo-
log ALDH2 acts in the major oxidative pathway of alcohol
metabolism; (ii) CYS4, cystathionine beta-synthase, that carries
out the ﬁrst committed step in cysteine biosynthesis, whereas
the human homolog CBS catalyzes the conversion of homocy-
steine to cystathionine, the ﬁrst step in the trans-sulfuration
pathway; (iii) Pyridoxine (pyridoxamine) phosphate oxidase
(PDX3), known to play a role in the synthesis of pyridoxal
5¢-phosphate in yeast, similar to the human homolog pyridox-
amine 5¢-phosphate oxidase (PNPO), which catalyzes the termi-
nal, rate-limiting step in the synthesis of pyridoxal 5¢-phosphate,
also known as vitamin B6. Interestingly, CBS requires vitamin B6
as a cofactor for the conversion of homocysteine to cystathio-
nine in human cells, suggesting that CBS and PNPO inﬂuence
aging via the same pathway. Importantly, none of these path-
ways have been linked to aging before, and future studies are
required to address the role of these proteins in multi-cellular
aging model systems including humans. As a ﬁrst step to vali-
date their relevance in human cellular senescence, expression
levels were analyzed in cellular extracts where antibodies were
available. We found differential regulation of ALDH2 and CBS
protein levels in several of our model systems (Fig. 2). Accord-
ingly, further studies are warranted to determine their role in
cellular senescence.
Experimental procedures
Cell isolation, cultivation, and characterization
Human diploid ﬁbroblasts from foreskin were seeded in 10-cm
dishes at a density of 200,000 cells per dish and treated in
parallel with the following compounds: untreated, vehicle trea-
ted (ethanol), oligomycin (8 lmol L
)1 ﬁnal concentration), FCCP
(3 lmol L
)1 ﬁnal concentration), and AMP (3 lmol L
)1 ﬁnal
concentration). Every day, medium was replaced and inhibitory
compounds freshly added. This treatment leads to premature
senescence within 14 days (data not shown, see also (Stockl
et al., 2006, 2007; Zwerschke et al., 2003). RNA was prepared
after 72 h of incubation and analyzed by RNA proﬁling as
described earlier.
Human umbilical vein endothelial cells were isolated from
human umbilical veins and cultured in Endothelial Cell Basal
Medium (Lonza, Basel, Switzerland) supplemented with
endothelial cell growth medium (EGM) Single Quots (Lonza),
containing hEGF 0.5 mL, hydrocortisone 0.5 mL, GA-1000
0.5 mL, BBE 2.0 mL, and FBS 10.0 mL. The cells were subcul-
tured by trypsination with trypsin-EDTA (Gibco Life Technolo-
gies, Vienna, Austria), seeded on cell culture dishes coated with
0.2% gelatine and grown at 37 C at ambient atmosphere con-
taining 5% CO2. Cells were passaged at a ratio of 1:5 in regular
intervals. At later passages, the splitting ratio was reduced to
1:3 and 1:2, respectively. Cells were passaged before reaching
70–80% conﬂuence. Population doublings (PDL) were esti-
mated using the following equation: n = (log10 F ) log10
I)⁄0.301 (where n is the population doublings, F, number of cells
at the end of one passage, and I, number of cells that were
seeded at the beginning of one passage). After 50 PDL, the cells
reached growth arrest, and the senescent phenotype was veri-
ﬁed by staining for senescence-associated beta galactosidase,
which was positive for ‡ 95% of cells.
Human primary PrSC were established and trans-differentia-
tion induced by TGF-beta1 treatment, as described (Untergasser
et al., 2005). Brieﬂy, PrSC were derived from prostate cancer
patients who have not received hormonal therapy (n = 3, age
65–72) after obtaining written informed consent. After radical
prostatectomy and inspection by the pathologist, two tissue
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1092wedges showing no histological signs of malignancy were
removed from the transition zone. These explants were minced
into organoids of   1m m
3 and seeded on uncoated plastic
material in stromal cell growth medium containing insulin,
human basic ﬁbroblast growth factor, 5% fetal calf serum, and
gentamycin and amphotericin-B as antibiotics (SCGM; Lonza).
Explants were maintained at 37 C in a humidiﬁed atmosphere
of 5% CO2. These conditions produce a homogeneous ﬁbro-
blast cell population after 7 days of culture. When cells reached
70% conﬂuence, they were split at a 1:3 ratio using trypsin-
EDTA to expand the population. In all experiments, cells of
passage 2–4 were used directly from culture (not previously
frozen).
Renal proximal tubular epithelial cells were cultivated as
recently reported (Wieser et al., 2008). In brief, within 24 h after
surgery, tissue from the renal cortex was fragmented and
incubated at 37 C for 15–20 min in DMEM⁄Ham’s F12 (1:1)
(Biochrom KG, Berlin, Germany) containing 1 mg mL
)1 collage-
nase type IV (PAN-BioTech GmbH, Aidenbach, Germany) and
1m gm L
)1 trypsin-inhibitor (Sigma, Vienna, Austria). After
being passed through a 105-lm nylon mesh, the ﬁltrate was
centrifuged, washed twice with phosphate-buffered saline
(PBS), resuspended in medium, and dispensed into roux-ﬂasks
(Nunc, Wiesbaden, Germany). 24 hours thereafter medium was
changed. The initial passage of conﬂuent cells after 3–5 days
was considered as PDL zero. Cells were passaged (1:2 to 1:4) at
conﬂuence, using 0.25% trypsin⁄0.02% EDTA, which was inac-
tivated with 1 mg mL
)1 trypsin-inhibitor. Cumulative PDL was
calculated as a function of passage number and split ratio (4).
Medium consisted of DMEM⁄Ham’s F12 (1:1) supplemented
with 4 mML -glutamine, 10 mM HEPES buffer, 5 pM tri-iodothyr-
onine, 10 ng mL
)1 recombinant human EGF, 3.5 lgm L
)1
ascorbic acid, 5 lgm L
)1 transferrin, 5 lgm L
)1 insulin,
25 ng mL
)1 prostaglandin E1, 25 ng mL
)1 hydrocortisone, and
8.65 ng mL
)1 sodium selenite (all from Sigma). After 24 PDL,
the cells reached growth arrest, and the senescent phenotype
was veriﬁed by staining for senescence-associated beta galacto-
sidase, which was positive for ‡ 95% of cells. Cells at intermedi-
ate passage could be divided into two groups concerning their
redox status, as monitored by dichloroﬂuorescein diacetate
(DCFDA) staining. To address the signiﬁcance of this distinction,
RPTECs were sorted into DCFDA
bright and DCFDA
dim subpopula-
tions, which were analyzed separately.
Mesenchymal stem cells were isolated from the iliac crest of
systemically healthy individuals (young donor, age 5; elderly
donor, age 56), which had been harvested for reconstructive
bone surgery of defects within other areas of the body as
described previously (Fehrer et al., 2007). Brieﬂy, a small biopsy
of substantia spongiosa osseum, which otherwise would have
been discarded based on necessary bone for molding and
re-contouring prior to insertion into the recipient site, was taken
to further investigation under an Institutional Review Board-
approved protocol after having obtained the parents’ and the
respective patient’s written consent. After surgery, the bone
was transferred into minimal essential medium (MEM) supple-
mented with 20% heat-inactivated fetal calf serum,
100 units mL
)1 penicillin, and 100 lgm L
)1 streptomycin
(growth medium) for transportation from the operation theater
to the clean room at room temperature. The biopsies were frag-
mented, and marrow cells were isolated from pieces (20–
100 mm
3) by centrifugation (400 g, 1 min). After centrifuga-
tion, the remaining pieces were treated with collagenase
(2.5 mg mL
)1 in MEM) for 2–3 h at 37 C, 20% O2, and 5%
CO2. Thereafter, the specimen was again centrifuged (400 g,
1 min). Cells were resuspended and loaded on a Ficoll-Paque
Plus
  gradient and centrifuged at 2500 g for 30 min. Cells were
harvested from the interphase (density < 1.075 g mL
)1),
washed, and collected by centrifugation (1500 g, 15 min). Cells
were cultured at a density of 0.2–0.5 · 10
6 cells cm
)2 at either
20% or 3% O2 in combination with 5% CO2 and 37 C (Hera-
Cell240 – Heraeus, Thermo Scientiﬁc, Vienna, Austria; Thermo
Electron Forma Series II, 3110). After 24 h, the nonadherent cell
fraction was removed by washing twice with PBS. After the pri-
mary culture had reached approximately 30–50% conﬂuence,
cells were washed twice with PBS and subsequently treated with
0.05% trypsin⁄1m M EDTA for 3–5 min at 37 C. Cells were
harvested, washed in MEM, and further expanded at a density
of 50 cells cm
)2.
Isolation of CD8
+CD28
+ and CD8
+CD28
) T cells from periph-
eral blood of apparently healthy young (< 35 year, n = 6, mean
age 29, range 26–35) and elderly (> 65 year, n = 10, mean age
72, range 66–87) donors was performed by preparing peripheral
blood mononuclear cells (PBMCs) by Ficoll-Paque PLUS (Amer-
sham Biosciences) density gradient centrifugation as approved
by the Ethics committee of Innsbruck Medical University. CD8
+ T
cells were negatively selected from the obtained PBMC fraction
by applying the magnetic separation protocol CD8
+ T cell isola-
tion kit II (depleting CD4, CD14, CD16, CD19, CD36, CD56,
CD123, TCRc⁄d, and CD235a; Miltenyi Biotec, Bergisch Glad-
bach, Germany) according to the manufacturer’s instructions.
Subsequently, puriﬁed CD8
+ T cells were stained with an allo-
phycocyanin (APC)-conjugated aCD28 monoclonal antibody
(mAb) and split into CD8
+CD28
+ and CD8
+CD28
) T-cell popula-
tions using aAPC MicroBeads (Miltenyi Biotec) by passing the
cell suspension through a positive selection column (LS; Miltenyi
Biotec) mounted in a magnetic ﬁeld. The CD8
+CD28
) T-cell frac-
tion was then re-incubated with aAPC MicroBeads and run over
a fresh LS-column to increase purity. For phenotypic analysis,
puriﬁed T-cell fractions were labelled with a combination of
mAbs (aTCRab-FITC, aCD16-PE, aCD4-PerCP, aCD8-PE-Cy7,
aCD28-APC, and aCD3-APC-Cy7; all BD Biosciences, Heidel-
berg, Germany) and analyzed on a FACSCanto II (BD Bio-
sciences) revealing that the described isolation protocol yields
population homogeneities of > 95%.
Applying oxidative stress by tBHP treatment
Human umbilical vein endothelial cells, PrSC, RPTEC, and CD8
+
T lymphocytes were treated by exposure to sublethal doses of
tBHP (Unterluggauer et al., 2003). Induction of senescence by
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(Unterluggauer et al., 2003, and data not shown). To identify
early transcriptional events involved in the senescence response,
cells were analyzed 3 days after starting the treatment.
RNA Isolation, whole-genome array analysis of
mRNA expression, and quantitative PCR
RNA was isolated using either Tri Reagent (Sigma-Aldrich) or
performing homogenization in 4.2 M guanidinium thiocyanate
before phenol extraction and ethanol precipitation (Chomczyn-
ski & Sacchi, 1987), followed by LiCl precipitation at a ﬁnal con-
centration of 4.5 M. Whole-genome expression analysis was
carried out on GeneChip HG-U133 Plus 2.0 Arrays (Affymetrix)
by MFT Services, Tuebingen, Germany.
Bioinformatics, clustering, and visualization of array
data
Array raw data were normalized via CARMAweb (Rainer et al.,
2006) using the gcrma algorithm (Wu et al., 2004). Hierarchical
clustering of samples and genes (Euclidian distance, average
linkage) was performed after ﬁltering out genes with low vari-
ance on a subset of 20 000 genes with the MeV program pack-
age (Saeed et al., 2006) available online: http://www.tm4.org/
mev/).
To evaluate the probability of observing an elevated number
of under- or overexpressed gene occurrences, the distinct num-
ber of occurrences in which the gene is under- or overexpressed
in a respective group of experiments was determined. The
resulting gene list was ranked according to occurrences with
respect to either age⁄senescence-related model systems or oxi-
dative stress–derived data sets as well as a gene list of highly
under- or overrepresented candidates present in both cases.
Statistical analysis to identify signiﬁcant probe sets was per-
formed as described by de Magalhaes et al. (2009a,b): For each
probe set, a P-value was calculated with the cumulative binomial
distribution (CBD):
PðX   kÞ¼
X n
j¼k
n
j
  
p j 1   p ðÞ
n j
providing the probability P for a probe set to be as often or
more often differentially expressed than the times k, it was
actually differentially expressed in n experiments. The threshold
for differential expression of a probe set was deﬁned as a fold
change between samples ‡ ±1.5. Applying statistical analysis
based on CBD, the probability P that any probe set is differen-
tially expressed with senescence or oxidative stress was deﬁned
as the average of differentially expressed probe sets in the
experimental group senescence or oxidative stress divided by
the number of all probe sets per whole-genome analysis.
The q-value was calculated for each probe set using Storey’s
false discovery rate (FDR) approach with the bootstrapping
method (Storey et al., 2004). The robust parameter was used to
make the q-values more accurate for small P-values (Storey,
2002). Statistical computation was carried out using the statis-
tical framework R (R-Team, 2007) version 2.5.1. Bioconductor
q-value package version 1.10.0 (Storey & Tibshirani, 2003) was
used to calculate the FDR.
Differentially expressed genes were grouped into protein fam-
ilies associated with characterized pathways applying Pathway
Explorer ((Mlecnik et al., 2005), available online: https://path
wayexplorer.genome.tugraz.at/), P-values were calculated from
the complete expression value dataset (54 675 probe sets) with
Fisher’s exact test, pathway data sources: KEGG pathway data-
base (http://www.genome.jp/kegg/pathway.html), GenMapp
(http://www.genmapp.org/), Biocarta (http://www.biocarta.
com/genes/).
Database
GiSAO.db (https://gisao.genome.tugraz.at) is a web-based data-
base system for storing and retrieving data of genes involved in
senescence, apoptosis, and oxidative stress. The application is
based on a three-tier architecture consisting of a web interface,
business logic, and a database. The web interface enables data
input and presentation. It was implemented by using Struts
framework (http://struts.apache.org/) with Java Server Pages
(http://java.sun.com/products/jsp/). The business logic, which is
responsible for data processing is an Enterprise JavaBeans 3
(http://java.sun.com/products/ejb/) application deployed on
JBoss (http://www.jboss.org/jbossas/) application server. The
data are stored in an Oracle database, a relational database
management system.
The GiSAO database contains normalized gene expression
values obtained from experiments evaluated with the aid of
Affymetrix arrays. Gene expression values of each experiment
can be displayed and compared with the gene expression values
of two or more microarray experiments. Additionally, experi-
mental data of follow-up experiments regarding candidate
genes, such as qPCR or Western Blot analysis, are entered into
the GiSAO.db. Furthermore, GiSAO.db contains two types of or-
thologue data: orthologue data provided and updated by
Affymetrix from cross reference tables linking Saccharomyces
cerevisiae, Caenorhabditis elegans, Drosophila melanogaster,
Musmusculus and Homo sapiens facilitate comparative genomic
analyses, as well as orthology data computed and entered man-
ually. Besides mRNA expression proﬁles, also data from prote-
ome analysis and further validation with respect to functional
analyses together with information from public resources are
available for distinct candidate genes. Moreover, external links
lead to orthologs of HomoloGene (http://www.ncbi.nlm.nih.
gov/homologene) and InParanoid (http://inparanoid.sbc.su.se/
cgi-bin/index.cgi). The gene IDs are linked to their respective
database, such as Entrez Gene or RefSeq. GiSAO.db also pro-
vides gene annotation (Gene Symbol, Gene Name, etc.) and GO
terms (http://www.geneontology.org/). Finally, KEGG pathways
(http://www.genome.jp/kegg/) can be displayed and data can
be exported in various formats.
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Sacharomyces cerevisiae
Either previously assigned cross references distinctly referring
to homologous gene identiﬁers from other species provided
in the array annotation tables accompanying the Affymetrix
gene chip or data from reciprocal-best-ﬁt-protein-homology
searches (Moreno-Hagelsieb & Latimer, 2008) were employed
to deﬁne the closest homologous gene pair between man
and yeast. Only orthologous genes, which were found non-
essential after genomic deletion in yeast laboratory strains
(http://mips.helmholtz-muenchen.de/proj/eurofan/eurofan_1/b0/
search/simpleSearch.html) were selected for further functional
analyses.
Lifespan analysis of gene disruption mutants of
Sacharomyces cerevisiae
Experiments were carried out in BY4741 (MATa his3D1 leu2D0
met15D0 ura3D0) as the wild-type strain and respective null
mutants, obtained from Euroscarf. Strains were grown at 28 C
on SC medium containing 0.17% yeast nitrogen base (Difco),
0.5% (NH4)2SO4 and 30 mg L
)1 of all amino acids (except
80 mg L
)1 histidine and 200 mg L
)1 leucine), 30 mg L
)1 ade-
nine, and 320 mg L
)1 uracil with 2% glucose. For all experi-
ments, yeast cells were grown at 28 C and 145 rpm. For
chronological lifespan experiments, cultures were inoculated at
an OD600 of 0.1, and aliquots were taken to perform survival
plating at indicated time points.
Statistics
All values were expressed as means ± standard deviation of the
mean. Statistical differences of experimental scores were evalu-
ated using Student’s t tests. Differences were considered signiﬁ-
cant when P was < 0.05.
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Fig. S1 Validation of microarray analysis: expression values of 22
genes exhibiting differential expression of > 1.5-fold in more
than 18 of 37 experimental pairs were assessed by quantitative
reverse transcription–PCR.
Fig. S2 Hierarchical clustering of genome-wide gene expression
proﬁles derived from all experimental human cell models (47
individual datasets).
Fig. S3 Comparison of numbers of differentially expressed
probe sets (DE > 1.5) between individual members of EG2.
Table S1 Experimental systems: HUVEC (human umbilical vein
epithelial cells), PFF (primary foreskin ﬁbroblasts), PrSC (primary
prostate stromal cells), RPTEC (renal proximal tubular epithelial
cells), CD8 (CD8
+ T lymphocytes), MSC (mesenchymal stem
cells), Reagents: bFGF: basic ﬁbroblast growth factor, TGFb:
transforming growth factor-b 1, t-BHP (tert-butylhydroper-
oxide), FCCP (carbonyl cyanide 4-(triﬂuoromethoxy)phenyl-
hydrazone), AMP (adenosine monophosphate), DCFDA (2¢,7¢-
dichloroﬂuorescein diacetate), number of up- and downregulat-
ed probe sets for each array experiment (DE > 1.5, total probe
set number: 54 675 for Affymetrix U133 Plus 2.0 array)
Table S2 Genes that are differentially expressed (DE > 1.5) in
‡ 50% of the experiments for experimental groups 1 and 2,
numbers for up- and downregulation in EG1 and EG2, P-values
(cumulative binomial distribution), q-values (Storeys FDR
method)
Table S3 Three hundred and thirty-four genes differentially
expressed (DE > 1.5) with the highest combined score for both
experimental groups (‡ 18), provided as Excel ﬁle
Table S4 Highest scoring genes, which were found differen-
tially expressed (DE > 1.5) in both experimental groups, for
which an orthologous nonessential gene in yeast could be
identiﬁed (according to orthology information provided by
Affymetrix Inc
As a service to our authors and readers, this journal provides
supporting information supplied by the authors. Such materials
are peer-reviewed and may be re-organized for online delivery,
but are not copy-edited or typeset. Technical support issues aris-
ing from supporting information (other than missing ﬁles)
should be addressed to the authors.
Genetic regulators of cell aging, G. T. Laschober et al.
ª 2010 The Authors
Aging Cell ª 2010 Blackwell Publishing Ltd/Anatomical Society of Great Britain and Ireland
1097